Menu Search
Equities

KDA Group Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert
O1M:FRA

KDA Group Inc

Actions
  • Price (EUR)0.111
  • Today's Change-0.014 / -11.20%
  • Shares traded3.60k
  • 1 Year change-29.75%
  • Beta1.0139
Data delayed at least 15 minutes, as of Feb 16 2026 07:12 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

KDA Group Inc. is focused on the development and marketing of its technological products and specialized software solutions for the healthcare market. The Company operates through Pharmaceutical Technology segment. It is focused on developing technological products across four different platforms: KRx, Medherize, CareMedic and Adherize+. The KRx is an advanced electronic prescription platform that simplifies and secures the prescribing process for medical clinics. Medherize is a specialized module of Adherize+, which focuses on patients undergoing complex therapies, such as oral oncology treatments. CareMedic is its integrated digital health record and care coordination platform. It centralizes patient information, including medical history, lab results, allergies, and medication schedules and enables secure communication among providers and with patients. Adherize+ is an intelligent patient engagement platform designed to monitor treatment adherence and provide tailored interventions.

  • Revenue in CAD (TTM)251.92k
  • Net income in CAD-7.17m
  • Incorporated2008
  • Employees--
  • Location
    KDA Group IncBureau 300, 1351, rue Notre-Dame EstTHETFORD MINES G6G 0G5CanadaCAN
  • Phone+1 (514) 715-0376
  • Fax+1 (418) 755-0822
  • Websitehttp://www.alliancepharma.ca/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status		KDA:CVE since
announced		Transaction
value
Groupe Technologique KDA IncAnnounced25 Nov 202525 Nov 2025Announced-12.50%6.08m
Data delayed at least 15 minutes, as of Feb 13 2026 18:43 GMT.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.